Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer
Zhang, Chen X, Huang, Sui, Xu, Nong, Fang, Jia W, Shen, Peng, Bao, Yin H, Mou, Bo H, Shi, Ming G, Zhong, Xing L, Xiong, Ping J
Published in Anti-cancer drugs (01.06.2007)
Published in Anti-cancer drugs (01.06.2007)
Get more information
Journal Article